Michel Vulfovich, MD, discusses molecular testing in colorectal cancer.
Michel Vulfovich, MD
Advertisement
Articles by Michel Vulfovich, MD
Michel Vulfovich, MD, medical director, Sickle Cell Disease and Gynecology Oncology programs, Memorial Healthcare System, discusses the utility of broad molecular profiling in metastatic colorectal cancer (mCRC).
Advertisement
Latest Updated Articles
Dr. Vulfovich on Broad Molecular Profiling in mCRCPublished: December 20th 2019 | Updated:
Dr. Vulfovich on Molecular Testing in Colorectal CancerPublished: January 7th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5